China awards generics contracts to lowest bidders
26-09-2019
Gilead challenges US govt patents on HIV drug Truvada
22-08-2019
Gilead claims US government PrEP patents are invalid
20-05-2019
Mark Van Scyoc / Shutterstock.com
A US congressman and senator have asked the country’s audit institution, the Government Accountability Office (GAO) to review the management of government-owned IP in the health sector.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Gilead Sciences, Government Accountability Office,Department of Health and Human Services, patent infringement, HIV
